Is Total Arterial Revascularization Superior to Multiarterial Grafting in Coronary Artery Bypass Grafting

Completed

• Conditions: CABG; Revascularization

• Registration Number: NCT06766084
• Lead Sponsor: Technion, Israel Institute of Technology

Brief Summary

Retrospective study of adult patients with multivessel disease undergoing isolated coronary artery bypass grafting (CABG) in three centers between January 1st, 2009, and December 31st, 2023. Patients were grouped according to the revascularization strategy (total arterial revascularization vs. multiarterial grafting). Primary outcome was a composite of major adverse cardiac and cerebrovascular events (MACCE).

Detailed Description

Not available

Study Timeline

• Study Start: 2009-01-01
• Primary Completion: 2023-12-31
• Study Completion: 2023-12-31
• Status Verified: 2025-01
• Study First Submitted: 2025-01-02
• Study First Submitted QC: 2025-01-08
• Last Update Submitted: 2025-01-08
• Study First Posted: 2025-01-09
• Last Update Posted: 2025-01-09

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 7878

Inclusion Criteria

• isolated CABG

Exclusion Criteria

• single vessel CABG
• CABG with utilization of only one arterial graft

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
MACCE	through study completion, a median of 101 months

Secondary Outcome Measures

Name	Time	Method
Mortality	through study completion, a median of 101 months
MI	through study completion, a median of 101 months
CVA	through study completion, a median of 101 months
repeat revascularization	through study completion, a median of 101 months